1. ® https://products.sanofi.us/lantus/lantus.html
2. Eli Lilly and Company European Commission grants Lilly and Boehringer Ingelheim's insulin glargine product marketing authorisation in Europe 2014 http://investor.lilly.com/releasedetail.cfm?ReleaseID=870088
3. European Medicines Agency Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues 2015 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184161.pdf
4. US Food and Drug Administration Scientific considerations in demonstrating biosimilarity to a reference product. Guidance for industry 2015 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291128.pdf
5. US Food and Drug Administration Quality considerations in demonstrating biosimilarity of a therapeutic protein product to a reference protein product. Guidance for industry 2015 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291134.pdf